A 10-day low-dose Dacogen regimen showed a 33% response rate in myelofibrosis patients, with a median response duration of seven months. High prognostic scores, elevated fetal hemoglobin, and reduced ...
In patients with inborn errors of immunity who are prone to viral infections, immunoglobulin replacement therapy (IRT) administered via the conventional subcutaneous route showed lower viral infection ...
Please provide your email address to receive an email when new articles are posted on . Despite the benefits and accessibility of administering cancer medications and fluids subcutaneously vs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results